Literature DB >> 19244332

Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.

Vinod Nayak1, Moshe Dessau, Kaury Kucera, Karen Anthony, Michel Ledizet, Yorgo Modis.   

Abstract

Dengue virus relies on a conformational change in its envelope protein, E, to fuse the viral lipid membrane with the endosomal membrane and thereby deliver the viral genome into the cytosol. We have determined the crystal structure of a soluble fragment E (sE) of dengue virus type 1 (DEN-1). The protein is in the postfusion conformation even though it was not exposed to a lipid membrane or detergent. At the domain I-domain III interface, 4 polar residues form a tight cluster that is absent in other flaviviral postfusion structures. Two of these residues, His-282 and His-317, are conserved in flaviviruses and are part of the "pH sensor" that triggers the fusogenic conformational change in E, at the reduced pH of the endosome. In the fusion loop, Phe-108 adopts a distinct conformation, forming additional trimer contacts and filling the bowl-shaped concavity observed at the tip of the DEN-2 sE trimer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244332      PMCID: PMC2668458          DOI: 10.1128/JVI.02574-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.

Authors:  S L Allison; K Stiasny; K Stadler; C W Mandl; F X Heinz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  A quantitative model for membrane fusion based on low-energy intermediates.

Authors:  P I Kuzmin; J Zimmerberg; Y A Chizmadzhev; F S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

6.  Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin.

Authors:  Jason Wei-Ming Lee; Justin Jang-Hann Chu; Mah-Lee Ng
Journal:  J Biol Chem       Date:  2005-11-07       Impact factor: 5.157

8.  Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.

Authors:  Stéphane Bressanelli; Karin Stiasny; Steven L Allison; Enrico A Stura; Stéphane Duquerroy; Julien Lescar; Franz X Heinz; Félix A Rey
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

9.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  66 in total

1.  Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years.

Authors:  Yuxin Tang; Prinyada Rodpradit; Piyawan Chinnawirotpisan; Mammen P Mammen; Tao Li; Julia A Lynch; Robert Putnak; Chunlin Zhang
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein.

Authors:  Maofu Liao; Claudia Sánchez-San Martín; Aihua Zheng; Margaret Kielian
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Atomic-level functional model of dengue virus Envelope protein infectivity.

Authors:  Elizabeth A Christian; Kristen M Kahle; Kimberly Mattia; Bridget A Puffer; Jennifer M Pfaff; Adam Miller; Cheryl Paes; Edgar Davidson; Benjamin J Doranz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-24       Impact factor: 11.205

4.  Mutational analysis of the zippering reaction during flavivirus membrane fusion.

Authors:  Karen Pangerl; Franz X Heinz; Karin Stiasny
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein.

Authors:  Yan Zheng; Claudia Sánchez-San Martín; Zhao-ling Qin; Margaret Kielian
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.

Authors:  Kshatresh Dutta Dubey; Gargi Tiwari; Rajendra Prasad Ojha
Journal:  J Mol Model       Date:  2017-03-02       Impact factor: 1.810

7.  Structure of a dengue virus envelope protein late-stage fusion intermediate.

Authors:  Daryl E Klein; Jason L Choi; Stephen C Harrison
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

8.  Crystal structure of glycoprotein C from Rift Valley fever virus.

Authors:  Moshe Dessau; Yorgo Modis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

9.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

10.  A novel small molecule inhibitor of hepatitis C virus entry.

Authors:  Carl J Baldick; Michael J Wichroski; Annapurna Pendri; Ann W Walsh; Jie Fang; Charles E Mazzucco; Kevin A Pokornowski; Ronald E Rose; Betsy J Eggers; Mayla Hsu; Weixu Zhai; Guangzhi Zhai; Samuel W Gerritz; Michael A Poss; Nicholas A Meanwell; Mark I Cockett; Daniel J Tenney
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.